Background {#s1}
==========

Several pathogens have developed resistance against many of the currently available drugs and become a global health threat. Since infections caused by resistant pathogens are associated with higher morbidity and mortality than those caused by susceptible pathogens, increasing resistance is a major concern \[[@R01]\]. Also, while drug resistance is on the rise, discovery and development of newer drugs have been on the decline \[[@R02]\]. Thus, there is a pressing need for novel drugs to handle the problem of drug resistance. Genomic sequences of pathogens could serve as valuable tools in the search for newer drug targets. We employed an *in silico* approach to identify potential drug targets that could be exploited for drug discovery against some pathogens with reported drug resistance, *viz. Mycobacterium tuberculosis, M. leprae, Plasmodium falciparum, P. vivax, Staphylococcus aureus, Sterptococcus pneumoniae* and *Nesseirria gonorrhea*, and made the data available in the form of a database called DDTRP (Database of Drug Targets for Resistant Pathogens). The database can be accessed at <http://bmi.icmr.org.in/DDTRP>.

Methodology {#s2}
===========

From the list of currently available drugs for each of the selected pathogens, drugs reported to be associated with resistance due to mutation(s) in their respective target genes were selected and all enzymes involved in each of the targeted metabolic pathways were obtained from KEGG \[[@R03]\]. The protein sequences of these enzymes were compared with that of the human proteome using BLAST \[[@R04]\]. Proteins that had no orthologs in human at an e-value of 0.005 were identified as potential drug targets and made available in the DDTRP. Each target is cross-linked to other useful online resources. The database was built using XAMPP. The flowchart describing the development of the DDTRP is given in [Figure 1](#F1){ref-type="fig"}.

Results and Discussion {#s3}
======================

Eighty six potential targets were identified for *M. tuberculosis*, 16 for *M. leprae*, 47 from *Staphylococcus aureus*, 43 for *Streptococcus pneumoniae*, 16 for *Plasmodium falciparum*, 11 for *Plasmodium vivax* and 46 for *Neisseria gonorrhoeae*. Raman *et al*., (2008) \[[@R05]\] used the method of predicting potential drug targets in *M. tuberculosis* by comparing its whole genome with that of human proteome. Other investigators like Anishetty *et al*., (2007) \[[@R06]\] and Agüero *et al*., (2008) \[[@R07]\] have undertaken various efforts to identify and prioritize targets for tropical diseases including tuberculosis. Our strategy differs from that of others in that we have chosen as our initial dataset proteins from resistance associated metabolic pathways for the prediction of alternate drug targets. A total of 265 proteins were identified by us as potential drug targets for the seven pathogens. Since these targets are involved in metabolic pathways that are known to be critical for the growth or survival of the pathogen and their interruption could bring about a static or cidal effect on the pathogen, the shortlisted targets could be prioritized for further studies. The contents of the database have been summarized in Table 1 (see [Table 1](#SD1){ref-type="supplementary-material"}).

Features of the database {#s4}
========================

The database has four browse options for each pathogen: currently available drugs with resistance,targets of current drugs,metabolic pathways involving each of the current targets, andpotential alternate drug targets. Details for each drug include a brief description of its composition and structure, mechanism of action, target protein, route of administration, dosage, absorption, adverse effects/toxicity and contra-indications. Links have also been provided to other online resources like DrugBank, PharmGKB, Medline Plus, DailyMed and RxList. Current and potential drug targets have been linked to GenBank, Swissprot (UniProt), KEGG, PDB, Pfam, InterPro, COG and other pathogen-specific databases wherever applicable. A provision has been made to browse the database via metabolic pathways. [Figure 2](#F2){ref-type="fig"} is a screen shot of the data provided for one of the potential targets in the database.

Future Developments {#s5}
===================

The database will be periodically updated with drug resistance related information and extended to include pathogens responsible for other emerging and re-emerging infectious diseases.

Conclusion {#s6}
==========

The Database of Drug Targets for Resistant Pathogens (DDTRP) is a comprehensive database that provides a list of current and alternative drug targets for a group of pathogens of public health significance. This database would be an useful online resource for researchers involved in target identification and drug discovery for various infectious diseases.

Supplementary material
======================

###### Data 1
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